Global Genetic Modification Therapies Clinical Applications 2017-2018 & 2023: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing” report has been added to ResearchAndMarkets.com’s offering.
The study scope includes clinical therapies using gene editing, gene therapy, genetically modified cell therapy (chimeric antigen receptor T-cells, or CAR T-cells) or RNA therapy platforms.
Delivery technologies covered include AAV, adenovirus, lentivirus, retrovirus, other viral and nonviral. Disease areas covered include cardiology, oncology, ophthalmology, hematology, musculoskeletal, neurology, rare diseases and others. Therapies that are already commercialized or are forecast to be commercialized with the next five years are included.
We analyze key genetic modification therapy technologies and products to determine present and future market status and forecasted growth from 2018 through 2023. We also discuss strategic alliances, industry structures, competitive dynamics, patents and market driving forces.
This Research examines the genetic modification therapies industry by market segment, including the following segments: gene editing, gene therapy, CAR T-cell therapy, RNA therapy and lentiviral production. The geographic market for genetic modification therapy products by platform technology is analyzed. The role of key strategic alliances and acquisitions from Jan. 2016 through June 2018 is discussed.
The challenges involved with pricing for genetic modification therapies that can offer one-time cures for diseases is discussed. Emerging markets for clinical gene editing are analyzed. More than 145 companies in the genetic modification therapies industry are profiled. Profiles of the key companies in the market, including 4d Molecular Therapeutics LLC, Abeona Therapeutics LLC, Acer Therapeutics Inc., Allergan Plc and American Gene Technologies International Inc.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 OverviewScope of Report Genetic Modification Therapies Covered in Report Genetic Modification Therapy Platform Technologies Forces Driving the Growth of the Market for Genetic Modification Therapies Global Market for Genetic Modification Therapies Life-Cycle Status of Products and Technologies Genetic Modification Therapies Industry
Chapter 4 TechnologyIntroduction to Genetic Technology Genetic Variation and Analysis Genetic Modification Therapies Gene Therapy Technologies RNA Therapy Technologies Gene Editing Technologies Genetically Modified Cell Therapy Technologies Delivery Technologies Introduction Viral Delivery Technologies Nonviral Delivery Technologies Design and Manufacture of a Gene Therapy Medicine
Chapter 5 Genetic Modification Therapy Applications
Chapter 6 Genetic Modification Therapies IndustrySummary Gene Editing Industry Gene Therapy Industry Genetically Modified Cell Therapy Industry RNA Therapy Industry Lentivirus Production Industry
Chapter 7 Acquisitions and Strategic AlliancesAcquisitions Strategic Alliances
Chapter 8 Markets for Genetic Modification TherapiesGrowth Driving Forces Payment and Business Models for Genetic Modification Therapeutics Market for Genetic Modification Therapies Genetic Modification Therapies by Platform Technology Genetic Modification Therapies by Disease Category Genetic Modification Therapies by Delivery Technology Genetic Modification Therapies by Indication Genetic Modification Therapies by Region
Chapter 9 PatentsGene Editing-Related Patents Gene Editing Patents-Sangamo Case Study Gene Therapy Delivery Patents RNA Therapy-Related Patents CAR T-cell Patents
Chapter 10 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/l5qd2v/global_genetic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005647/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/27/2018 11:20 AM/DISC: 09/27/2018 11:20 AM